内皮型一氧化氮合酶基因启动子多态性rs3918226作为外周动脉疾病新型易感标志物
这项先导研究在1263名斯拉夫裔无关个体(620例外周动脉疾病患者和643名对照)中,用MassArray-4系统对NOS3基因启动子单核苷酸多态性rs3918226进行基因分型,发现该多态性与外周动脉疾病风险升高相关(OR=2.86;95%CI 1.89-4.32;Pperm<0.0001),且女性关联强度约为男性3倍。
要点
- rs3918226多态性与外周动脉疾病风险升高相关(OR=2.86;95%CI 1.89-4.32;Pperm<0.0001)。
- 女性关联强度约为男性3倍:女性OR=8.31(95%CI 3.07-22.48),男性OR=1.79(95%CI 1.10-2.93)。
- rs3918226-T等位基因与NOS3表达降低相关,在胫动脉中强于冠状动脉或主动脉。
核心结论
- 本研究首次表明NOS3基因rs3918226多态性是外周动脉疾病的新型易感标志物。
- 需在独立人群中进一步研究以重复rs3918226多态性与疾病风险的关联。
研究设计与样本
- 先导研究纳入1263名斯拉夫裔无关受试者,包括620例外周动脉疾病患者和643名对照。
- 采用MassArray-4系统对单核苷酸多态性rs3918226进行基因分型。
主要发现
- rs3918226多态性与外周动脉疾病风险升高强烈相关,且不受冠状动脉疾病、高血压或吸烟影响(OR=2.86;95%CI 1.89-4.32;Pperm<0.0001)。
- 女性关联强度约为男性3倍:女性OR=8.31(95%CI 3.07-22.48),男性OR=1.79(95%CI 1.10-2.93)。
- 在外周动脉疾病患者中,rs3918226与踝肱指数和总血浆胆固醇相关(Pperm<0.05)。
- NOS3多态性与GUCY1A3基因的rs7692387和rs13139571紧密关联以决定外周动脉疾病风险,提示rs3918226可能破坏NO-可溶性鸟苷酸环化酶通路信号传导。
- 携带野生型等位基因的双体型如NOS3 rs3918226-C/C×GUCY1A1 rs7692387G/G和NOS3 rs3918226-C/C×GUCY1A1 rs13139571C/C显示对疾病风险的强保护作用(错误发现率≤0.001)。
关键数值与推荐
- 功能注释显示rs3918226-T等位基因与NOS3表达降低相关,在胫动脉中强于冠状动脉或主动脉。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需在独立人群中进一步研究以重复rs3918226多态性与疾病风险的关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This pilot study aimed to investigate the association between the single nucleotide polymorphism (SNP) rs3918226 in the promoter of the nitric oxide synthase (NOS3) gene and the risk of peripheral artery disease (PAD). METHODS: DNA samples from 1,263 unrelated subjects of Slavic origin, including 620 patients with PAD and 643 controls, were genotyped for the SNP rs3918226 using the MassArray-4 system. RESULTS: The rs3918226 polymorphism was found to be strongly associated with an increased risk of PAD regardless of coronary artery disease, hypertension, or cigarette smoking (odds ratio [OR] = 2.86; 95% confidence interval [CI] 1.89-4.32; Pperm < 0.0001). The SNP-PAD association was almost 3 times stronger in females (OR = 8.31; 95% CI 3.07-22.48) than in males (OR = 1.79; 95% CI 1.10-2.93). SNP rs3918226 was correlated with ankle-brachial index and total plasma cholesterol in patients with PAD (Рperm < 0.05). The NOS3 polymorphism was closely associated with SNPs rs7692387 and rs13139571 in guanylate cyclase soluble subunit alpha-3 (GUCY1A3) to determine the risk of PAD, suggesting that the rs3918226 polymorphism may disrupt signaling in the NO-soluble guanylyl cyclase pathway. Diplotypes with wild-type alleles, such as NOS3 rs3918226-C/C×GUCY1A1 rs7692387G/G and NOS3 rs3918226-C/C×GUCY1A1 rs13139571C/C, showed strong protection against disease risk (false discovery rate ≤ 0.001). Functional SNP annotation revealed that the allele rs3918226-T was associated with decreased expression of NOS3, most strongly in the tibial arteries than in the coronary artery or aorta. CONCLUSIONS: The present study is the first to show that the rs3918226 polymorphism of NOS3 is a novel susceptibility marker for PAD. Further research in independent populations is necessary to reproduce the association between polymorphism rs3918226 and disease risk.
引用
- Zhabin S, Lazarenko V, Azarova I, et al. The Promoter Polymorphism rs3918226 of the Endothelial Nitric Oxide Synthase Gene as a Novel Susceptibility Marker for Peripheral Artery Disease. Ann Vasc Surg. 2024. PMID: 39025213. doi:10.1016/j.avsg.2024.05.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。